These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 20399737

  • 1. The influence of ecto-nucleotidases on Leishmania amazonensis infection and immune response in C57B/6 mice.
    de Souza MC, de Assis EA, Gomes RS, Marques da Silva Ede A, Melo MN, Fietto JL, Afonso LC.
    Acta Trop; 2010 Sep; 115(3):262-9. PubMed ID: 20399737
    [Abstract] [Full Text] [Related]

  • 2. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E, Lang T, Glaichenhaus N, Antoine JC.
    J Immunol; 1996 Jun 01; 156(11):4318-27. PubMed ID: 8666803
    [Abstract] [Full Text] [Related]

  • 3. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth.
    González-Lombana CZ, Santiago HC, Macedo JP, Seixas VA, Russo RC, Tafuri WL, Afonso LC, Vieira LQ.
    Acta Trop; 2008 Apr 01; 106(1):27-38. PubMed ID: 18313021
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
    Aranha FC, Ribeiro U, Basse P, Corbett CE, Laurenti MD.
    Scand J Immunol; 2005 Oct 01; 62(4):334-41. PubMed ID: 16253120
    [Abstract] [Full Text] [Related]

  • 5. Leishmania amazonensis: Increase in ecto-ATPase activity and parasite burden of vinblastine-resistant protozoa.
    Giarola NL, Silveira TS, Inacio JD, Vieira LP, Almeida-Amaral EE, Meyer-Fernandes JR.
    Exp Parasitol; 2014 Nov 01; 146():25-33. PubMed ID: 25176449
    [Abstract] [Full Text] [Related]

  • 6. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ.
    Immunol Lett; 2006 May 15; 105(1):38-47. PubMed ID: 16466810
    [Abstract] [Full Text] [Related]

  • 7. Saliva of laboratory-reared Lutzomyia longipalpis exacerbates Leishmania (Leishmania) amazonensis infection more potently than saliva of wild-caught Lutzomyia longipalpis.
    Laurenti MD, Silveira VM, Secundino NF, Corbett CE, Pimenta PP.
    Parasitol Int; 2009 Sep 15; 58(3):220-6. PubMed ID: 19454323
    [Abstract] [Full Text] [Related]

  • 8. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H, Flohé S, Röllinghoff M.
    Eur J Immunol; 1995 Mar 15; 25(3):693-9. PubMed ID: 7705398
    [Abstract] [Full Text] [Related]

  • 9. CrATP interferes in the promastigote-macrophage interaction in Leishmania amazonensis infection.
    Ennes-Vidal V, Castro RO, Britto C, Barrabin H, D'Avila-Levy CM, Moreira OC.
    Parasitology; 2011 Jul 15; 138(8):960-8. PubMed ID: 21679488
    [Abstract] [Full Text] [Related]

  • 10. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA, Ogunremi O, Menon JN.
    Behring Inst Mitt; 1997 Feb 15; (98):153-9. PubMed ID: 9382736
    [Abstract] [Full Text] [Related]

  • 11. Leishmania amazonensis: characterization of an ecto-3'-nucleotidase activity and its possible role in virulence.
    Paletta-Silva R, Vieira DP, Vieira-Bernardo R, Majerowicz D, Gondim KC, Vannier-Santos MA, Lopes AH, Meyer-Fernandes JR.
    Exp Parasitol; 2011 Nov 15; 129(3):277-83. PubMed ID: 21827749
    [Abstract] [Full Text] [Related]

  • 12. Leishmania amazonensis impairs DC function by inhibiting CD40 expression via A2B adenosine receptor activation.
    Figueiredo AB, Serafim TD, Marques-da-Silva EA, Meyer-Fernandes JR, Afonso LC.
    Eur J Immunol; 2012 May 15; 42(5):1203-15. PubMed ID: 22311598
    [Abstract] [Full Text] [Related]

  • 13. The C-terminal extension of Leishmania pifanoi amastigote-specific cysteine proteinase Lpcys2: a putative function in macrophage infection.
    Marín-Villa M, Vargas-Inchaustegui DA, Chaves SP, Tempone AJ, Dutra JM, Soares MJ, Ueda-Nakamura T, Mendonça SC, Rossi-Bergmann B, Soong L, Traub-Csekö YM.
    Mol Biochem Parasitol; 2008 Nov 15; 162(1):52-9. PubMed ID: 18694784
    [Abstract] [Full Text] [Related]

  • 14. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 15; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 15. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection.
    Soong L, Chang CH, Sun J, Longley BJ, Ruddle NH, Flavell RA, McMahon-Pratt D.
    J Immunol; 1997 Jun 01; 158(11):5374-83. PubMed ID: 9164958
    [Abstract] [Full Text] [Related]

  • 16. NF-kappaB-mediated repression of iNOS expression in Leishmania amazonensis macrophage infection.
    Calegari-Silva TC, Pereira RM, De-Melo LD, Saraiva EM, Soares DC, Bellio M, Lopes UG.
    Immunol Lett; 2009 Dec 02; 127(1):19-26. PubMed ID: 19712696
    [Abstract] [Full Text] [Related]

  • 17. Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice.
    Lang T, Goyard S, Lebastard M, Milon G.
    Cell Microbiol; 2005 Mar 02; 7(3):383-92. PubMed ID: 15679841
    [Abstract] [Full Text] [Related]

  • 18. Systemic delivery of an adenovirus expressing EBV-derived vIL-10 in mice infected with Schistosoma mansoni or Leishmania amazonensis: controversial effects on the development of pathological parameters.
    Verwaerde C, Thiam K, Delanoye A, Fernandez-Gomez R, D'Halluin J, Auriault C.
    Eur Cytokine Netw; 1999 Jun 02; 10(2):161-70. PubMed ID: 10400822
    [Abstract] [Full Text] [Related]

  • 19. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR.
    Int Immunol; 2005 Oct 02; 17(10):1347-57. PubMed ID: 16141242
    [Abstract] [Full Text] [Related]

  • 20. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
    Pereira WK, Lonardoni MV, Grespan R, Caparroz-Assef SM, Cuman RK, Bersani-Amado CA.
    J Infect; 2005 Aug 02; 51(2):157-64. PubMed ID: 16038768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.